openPR Logo
Press release

Growth Of Genomic Biomarkers Market Driven By Personalized Medicine Demand: A Significant Driver Propelling The Genomic Biomarkers Market In 2025

06-03-2025 08:11 AM CET | Health & Medicine

Press release from: The Business Research Company

Genomic Biomarkers Market Size

Genomic Biomarkers Market Size

The Genomic Biomarkers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Genomic Biomarkers Market Size and Projected Growth Rate?
The genomic biomarkers market size has experienced rapid growth in recent years. It will grow from $7.42 billion in 2024 to $8.72 billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. This growth is driven by the increased emphasis on genetic testing activities, the rising incidence of chronic diseases, the focus on precision medicine initiatives, the growing adoption of companion diagnostics, and the increasing number of patients with neurological diseases.

The genomic biomarkers market is projected to reach $16.51 billion by 2029, growing at a CAGR of 17.3%. Growth is attributed to the rising incidence of ovarian and gastric cancers, growing genetic testing awareness, and the use of biomarkers in cancer diagnosis. Key trends include NGS advancements, integration with other omics, and innovations in genomic technologies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19485

What Are the Major Segments in the Genomic Biomarkers Market?
The genomic biomarkersmarket covered in this report is segmented -

1) By Type: Predictive Biomarkers, Prognostic Biomarkers
2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications
3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility
4) By End-User: Hospitals, Diagnostic Centers, Other End User

Subsegments:
1) By Predictive Biomarkers: Drug Response Biomarkers, Companion Diagnostics Biomarkers, Pharmacodynamic Biomarkers, Predictive Genetic Markers for Disease Susceptibility
2) By Prognostic Biomarkers: Cancer Prognostic Biomarkers, Cardiovascular Disease Prognostic Biomarkers, Neurodegenerative Disease Prognostic Biomarkers, Infectious Disease Prognostic Biomarkers

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19485&type=smp

What Are The Driving Genomic Biomarkers Market Evolution?
Growing demand for personalized medicine is expected to advance the genomic biomarkers market. This approach uses genetic information to tailor treatment plans. Factors such as EHR usage and genomic tech are fueling this trend. Genomic biomarkers help doctors choose targeted therapies based on an individual's genetic profile. In 2022, the Personalized Medicine Coalition reported that 12 new personalized therapies accounted for 34% of all drug approvals that year. Therefore, the trend toward precision medicine is propelling genomic biomarkers.

Which Firms Dominate The Genomic Biomarkers Market Segments?
Major companies operating in the genomic biomarkers market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Illumina Inc., PerkinElmer Inc., Almac Group, Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4

What Are the Latest Developing Trends in the Genomic Biomarkers Market?
In the genomic biomarkers market, major companies are innovating products like lung reagents to improve the detection of genetic mutations in lung cancer, which helps with accurate diagnosis and personalized treatment. Lung reagents are used in diagnostic tests and medical procedures related to lung health. For example, Biofidelity, a UK company, launched ASPYRE-Lung reagents in December 2023, designed to identify key genetic mutations critical for guiding targeted therapies in lung cancer treatment.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/genomic-biomarkers-global-market-report

Which Is The Largest Region In The Genomic Biomarkers Market?
North America was the largest region in the genomic biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Genomic Biomarkers Market?
2. What is the CAGR expected in the Genomic Biomarkers Market?
3. What Are the Key Innovations Transforming the Genomic Biomarkers Industry?
4. Which Region Is Leading the Genomic Biomarkers Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growth Of Genomic Biomarkers Market Driven By Personalized Medicine Demand: A Significant Driver Propelling The Genomic Biomarkers Market In 2025 here

News-ID: 4048127 • Views:

More Releases from The Business Research Company

Emerging Trends to Reshape the Xenotransplantation Market: Xvivo's Innovative Preservation Technology Paves The Way For Xenotransplantation Advancements as a Key Influencer
Emerging Trends to Reshape the Xenotransplantation Market: Xvivo's Innovative Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Xenotransplantation Market Size By 2025? The market size of xenotransplantation has seen robust expansion in the past few years. The market value is projected to increase from $14.68 billion in 2024 to $15.82 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.8%.
Wood Based Panel Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Wood Based Panel Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Wood Based Panel Market Through 2025? In recent times, the market size of wood-based panels has seen considerable growth. The market which was valued at $176.85 billion in 2024 is projected to rise to $190.52 billion in 2025, showing a compound annual
Soaring Demand Set to Propel Wireless Speakers Market to $111.25 Billion by 2029
Soaring Demand Set to Propel Wireless Speakers Market to $111.25 Billion by 2029
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Wireless Speakers Market Size Growth Forecast: What to Expect by 2025? In recent times, the wireless speakers market has experienced substantial expansion. The market size is expected to increase from $37.14 billion in 2024 to $45.71 billion in 2025, growing at a compound annual growth rate (CAGR) of 23.1%.
Wind Turbine Casting Market Landscape 2025: Forecast Data and Growth Strategy Insights
Wind Turbine Casting Market Landscape 2025: Forecast Data and Growth Strategy In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Wind Turbine Casting Industry Market Size Be by 2025? The market size for wind turbine castings has seen solid growth in the past few years. Its value is projected to increase from $2.31 billion in 2024 to $2.46 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Biomarkers

Biomarkers Market Soars: Safety Biomarkers Lead with 15.9% Projected Growth from …
The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022-2032. Biomarkers, or biological indicators, have revolutionized the fields of medicine and healthcare by enabling early disease detection, personalized treatment, and
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040 This latest report researches the industry structure, sales, revenue,
Cardiac Biomarkers Market - Unveiling Heart Health: Biomarkers Revolutionizing C …
Newark, New Castle, USA: The "Cardiac Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Biomarkers Market: https://www.growthplusreports.com/report/cardiac-biomarkers-market/8024 This latest report researches the industry structure, sales, revenue,
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out